Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H14FN3O |
InChIKeyLMXPZWQVDDSYHH-RYUDHWBXSA-N |
CAS Registry2268739-68-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Phase 1 | US | 19 Feb 2020 |